Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Aurobindo Pharma Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524804
ISIN Demat	INE406A01037
Book Value	379.18

NSE Code	AUROPHARMA
Dividend Yield %	0.00
Market Cap	869779.47

P/E	40.82
EPS	36.69
Face Value	1


	BSE		NSE

13-May-2026

Last Price	1497.55
Net Change	8.9
% Change	0.6%
Prev.Close	1488.65
Open	1488.10
High	1509.70
Low	1484.10
Volume	44402

Last Price	1497.50
Net Change	9.3
% Change	0.62%
Prev.Close	1488.20
Open	1490.00
High	1509.80
Low	1483.60
Volume	1821805

Value	66443507
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1509.70
52-Week High	1514.00
52-Week Low	1017.00

Value	2726123975.8
Best Buy	1497.50
Best Sell	0.00
Best Quantity	21
Sell Quantity	0
Today's Range	1509.80
52-Week High	1513.40
52-Week Low	1016.10

Open Price	1494.50
High Price	1516.80
Low Price	1489.10
Last Price	1504.60
Prev Close	1490.00
Change	14.60
% Change	0.98 %

Average Price	1503.65
Underlying Value	1497.50
Number of contracts traded	1825
Turnover in Rs. Lakhs	15093
Open Interest	18476700.00
Change in O I	60500.00
% Change in O I	0.33 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	21
Price	1497.50

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	550
Price	1503.3

Quantity	550
Price	1506

Holding Details

Latest Corporate Events

Bonus

1 : 1

20-Jul-15

Book Closure

23-Aug-23

25-Aug-23

Dividend

400 %

08-Aug-25

Company News

06-05-2026

Aurobindo Pharma informs...

06-05-2026

Aurobindo Pharma gets EIR...

06-05-2026

Aurobindo Pharma zooms af...

02-05-2026

Aurobindo Pharma’s arm ge...

21-04-2026

Letter Of Offer For Buy...

18-04-2026

Aurobindo gets nod for De...

17-04-2026

Aurobindo Pharma gets USF...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.